M·CAM | Should the government be blamed for EpiPen price hike?

23597

post-template-default,single,single-post,postid-23597,single-format-standard,ajax_fade,page_not_loaded,,select-theme-ver-4.1,wpb-js-composer js-comp-ver-7.9,vc_responsive

August 26, 2016 In Business Events, CNBC IQ100 Archive

Should the government be blamed for EpiPen price hike?

Should the government be blamed for EpiPen price hike? from CNBC.

Should the government be blamed for EpiPen price hike?

4:26 PM ET Fri, 26 Aug 2016

David Martin, M-CAM Founder, discusses the EpiPen pricing saga and his view that the patent office gave Mylan an unjustified monopoly on the drug.

No Comments

Sorry, the comment form is closed at this time.